Latest briefing
What's happening with SCNI Stock Titan 9 Jul 2026
LCK JNK 1 LLC takes 6.33% stake in Scinai Immunotherapeutics (SCNI) - Stock Titan <a href="https://news.google.com/rss/articles/CBMiywFBVV95cUxQQWZkQ0hBLUM5UERzUjBHMVNIbEVlY1gtSE9ZUTFqUnJpaTB6RXcwak9FQmk3VWgtRzZ0MW95ZjRidGF5S2tEd1daU0xLZTJsYVk5cTRmX0NiWTVkOXNHRTZ5Y3JxVldMb01QNjM2NjRjTWhCYThiOVVUU1IwMUJPbE1KdzJUSUtTMDljYWlvZ053WU45SmZDV1RDM3VTa01pOHJXUzlhZ1Z6NG9HT1BXS3VXU0IyQUpWbExVNkZoVE5Rb2NSWmU2YUZpaw?oc=5" target="_blank">LCK JNK 1 LLC takes 6.33% stake in Scinai Immunotherapeutics (SCNI)</a> <font color="#6f6f6f">Stock Titan</font>
Why this matters▾
Article excerpt provided by the FMP news feed. AI is used only for the optional "Why this matters" read. Read full article ↗ dars.gov.et 1 Jul 2026
Scinai Immunotherapeutics (SCNI) Surges 7.68% as Speculative Interest Intensifies - Andrews Pitchfork - dars.gov.et <a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxPQlpHdFF2ZEdqX1hEdnRDS2lXMXAwSmttYnJQV2MycVNjMzIzSkZFNkc1bFg1Snp5MVRTcklpZmRxR3l4ajBNRkdYS1hlcnUzMWotUV8tU1lLbjI0aFZCUGNsb3F5WTR6MzFqZnpzWmRfNXdydEpUWHBJTzFkcmkxQ01YZ29uY29iblVBQmNuS2VQNFlvQkhHY05MdE9rSWxCZzE4Y0ZDMlVsZ0JuT3hqdDN4U3BZdkN1MGhHQ2Z3?oc=5" target="_blank">Scinai Immunotherapeutics (SCNI) Surges 7.68% as Speculative Interest Intensifies - Andrews Pitchfork</a> <font color="#6f6f6f">dars.gov.et</font>
Why this matters▾
Article excerpt provided by the FMP news feed. AI is used only for the optional "Why this matters" read. Read full article ↗ Stock Titan 18 Jun 2026
Scinai Immunotherapeutics (SCNI) director awarded 120M Ordinary Share RSUs - Stock Titan <a href="https://news.google.com/rss/articles/CBMiwAFBVV95cUxQQm95Q3ZLTE1aMWlKampITlA5ZERPUXFJS2F5TTBHR0ZGZFRzLTFmSlNMNktlNGhaMFpNaW5LVTdKR3phNlR4RTNvbGNHaFktazVvNTN4MC15X3FOVldEWDBkYU93aG1CbkkxME9NN0FIaUVzeHlta0o5UXo2RXFlbWFYVWswNXNMdVRfVkRJdGxwcTBfT2xVYzNhMjVfY3N1TVJCSjd1YlNJTkdTUk1JY29GVUdfSVdldlMyelRGT0U?oc=5" target="_blank">Scinai Immunotherapeutics (SCNI) director awarded 120M Ordinary Share RSUs</a> <font color="#6f6f6f">Stock Titan</font>
Why this matters▾
Article excerpt provided by the FMP news feed. AI is used only for the optional "Why this matters" read. Read full article ↗ Older updates drop into a lighter feed
Scinai Immunotherapeutics Announces $2.61 Million Private Placement Financing - PR Newswire
Read ↗ Scinai Immunotherapeutics Receives Nasdaq Notification Regarding Minimum Bid Price - Nasdaq
Read ↗ Scinai Immunotherapeutics (SCNI) Stock News - Stock Titan
Read ↗ Earnings news
SCNI earnings headlines This section is separated from the general news feed so investors can quickly connect the latest headlines with the structured earnings report.
Beyond the headline
A deeper look for beginners Generate a short AI read that goes beyond the headlines above, plus a plain-English breakdown of what it could mean going forward.
Generate AI Insight